Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve. Issue 1 (20th May 2020)

• Record Type: Journal Article
• Authors: Vining, Charles C.; Izquierdo, Francisco; Eng, Oliver S.; Turaga, Kiran K.
• Other Names: Hogg Melissa guestEditor.; Tseng Jennifer guestEditor.
• Is Part Of: Journal of surgical oncology. Volume 122:Issue 1(2020)
• Page Start: 85
• Page End: 95
• Publication Date: 2020-05-20
• Subjects: cytoreductive surgery -- HIPEC -- learning curve -- peritoneal metastasis -- surgical education; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.25939
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract: Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved safety and favorable oncologic outcomes, including curative potential. CRS/HIPEC has a steep learning curve and requires familiarity with peritonectomy procedures. This review will outline the technical aspects and learning curve of CRS/HIPEC.